C-MER Eye Care Holdings Limited provided earnings guidance for the six months ended 30 June 2023. For the period, profit attributable to shareholders of the Company for the six months ended 30 June 2023 ("1H2023") is expected to be in the range of HKD 25.0 million to HKD 30.0 million, or an increase of around 68% to 102%, as compared with profits of HKD 14.8 million for the same period last year. The expected increase in profit attributable to shareholders of the Company was primarily driven by an over 40% increase in revenue generated from medical service to approximately HKD 930.0 million in 1H2023 from HKD 660.8 million for the same period last year, partially net off by the reduction in revenue generated from sale of COVID-19 related medical consumables to approximately HKD 19.0 million in 1H2023 from HKD 220.7 million for the same period last year.